Your browser doesn't support javascript.
loading
Developing an immune signature for triple-negative breast cancer to predict prognosis and immune checkpoint inhibitor response.
Wang, Ce; Feng, Guoshuang; Zhu, Jingjing; Wei, Kecheng; Huang, Chen; Wu, Zhenyu; Yu, Yongfu; Qin, Guoyou.
Affiliation
  • Wang C; Department of Biostatistics, School of Public Health, & The Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China.
  • Feng G; Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University & Capital Medical University, Beijing 100083, China.
  • Zhu J; Big Data & Engineering Research Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.
  • Wei K; Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University & Capital Medical University, Beijing 100083, China.
  • Huang C; Department of Biostatistics, School of Public Health, & The Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China.
  • Wu Z; Department of Biostatistics, School of Public Health, & The Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China.
  • Yu Y; Department of Biostatistics, School of Public Health, & The Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China.
  • Qin G; Department of Biostatistics, School of Public Health, & The Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China.
Future Oncol ; 18(9): 1055-1066, 2022 Mar.
Article in En | MEDLINE | ID: mdl-35105171

Full text: 1 Database: MEDLINE Main subject: Prognosis / Gene Expression Regulation, Neoplastic / Triple Negative Breast Neoplasms / Immune Checkpoint Inhibitors Type of study: Evaluation_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Prognosis / Gene Expression Regulation, Neoplastic / Triple Negative Breast Neoplasms / Immune Checkpoint Inhibitors Type of study: Evaluation_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Year: 2022 Type: Article